Xeltis scored €45 million for its restorative, bioresorbable, polymer-based heart valve replacement technology.

The deal will see Roche work with Inotrem to develop an assay for measuring a biomarker correlated to negative outcomes in septic shock patients.

The 18-month study will assess whether Vectra DA delivers better outcomes and lower costs than conventional approaches.

Intuitive Surgical is dipping a toe into diagnostics—a new study showed its flexible robotics platform was used safely to take lung tissue samples.

Medtronic has posted a look at data on the first 50 patients treated with its transcatheter mitral valve replacement (TMVR) system.

The deal will see Thermo Fisher validate and seek approval for a test to identify RET fusions in non-small cell lung cancer patients.

The U.S. DOD is putting up the money to give the army a better way of assessing moderate to severe traumatic brain injuries in combat situations.

Gecko Biomedical’s first product may be a surgical sealant, but it has eyes on much more. The sealant's polymer has many potential applications.